Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.3 EUR | -1.22% | +0.84% | +0.75% |
05-17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
05-17 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Chart calendar Pfizer, Inc.
Upcoming events on Pfizer, Inc.
Past events on Pfizer, Inc.
08/05/2024 | Ex-dividend day |
01/05/2024 15:00 | Q1 2024 Earnings Call |
01/05/2024 11:45 | Q1 2024 Earnings Release |
25/04/2024 14:00 | Annual General Meeting |
12/03/2024 12:00 | Leerink Partners Global Biopharma Conference |
04/03/2024 16:10 | TD Cowen Health Care Conference |
29/02/2024 18:00 | Investor Day - Oncology Innovation |
30/01/2024 15:00 | Q4 2023 Earnings Call |
30/01/2024 11:45 | Q4 2023 Earnings Release |
24/01/2024 | Ex-dividend day |
08/01/2024 23:00 | JPMorgan Healthcare Conference |
13/12/2023 13:30 | Q4 2024 Guidance Call |
12/12/2023 01:15 | American Society of Hematology Meeting - Abstract Number -1054 |
12/12/2023 00:30 | American Society of Hematology Meeting - Abstract Number -1057 |
10/12/2023 00:45 | American Society of Hematology Meeting - Abstract Number -274 |
10/12/2023 00:30 | American Society of Hematology Meeting - Abstract Number -285 |
09/12/2023 17:45 | American Society of Hematology Meeting - Abstract Number -14 |
28/11/2023 15:50 | Evercore ISI HealthCONx Conference |
09/11/2023 17:35 | Truist Securities Healthcare Conference |
08/11/2023 | Ex-dividend day |
Past dividends on Pfizer, Inc.
08/05/2024 | Quarterly 0.42 USD |
24/01/2024 | Quarterly 0.42 USD |
08/11/2023 | Quarterly 0.41 USD |
26/07/2023 | Quarterly 0.41 USD |
10/05/2023 | Quarterly 0.41 USD |
25/01/2023 | Quarterly 0.41 USD |
02/11/2022 | Quarterly 0.4 USD |
27/07/2022 | Quarterly 0.4 USD |
11/05/2022 | Quarterly 0.4 USD |
26/01/2022 | Quarterly 0.4 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 51 750 51 807 -0.11% | 41 908 48 014 -12.72% | 81 288 81 781 -0.6% | 100 330 100 373 -0.04% | 58 496 59 105 -1.03% | 60 407 |
EBITDA Million USD | Released Forecast Spread | 21 097 22 824 -7.57% | 17 801 21 398 -16.81% | 25 426 29 444 -13.65% | 42 336 44 597 -5.07% | 15 590 11 249 38.59% | 21 189 |
EBIT Million USD | Released Forecast Spread | 19 420 19 883 -2.33% | 13 024 17 362 -24.99% | 20 235 26 662 -24.11% | 37 272 40 403 -7.75% | 9 300 8 509 9.3% | 17 050 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17 682 22 426 -21.15% | 7 497 13 166 -43.06% | 24 311 19 569 24.23% | 34 729 39 058 -11.08% | 1 058 2 301 -54.02% | 11 020 |
Net income Million USD | Released Forecast Spread | 16 273 19 053 -14.59% | 9 616 16 066 -40.15% | 21 979 22 567 -2.6% | 31 372 33 053 -5.09% | 2 119 3 040 -30.29% | 7 775 |
EPS USD | Released Forecast Spread | 2,87 3,40 -15.62% | 1,71 3,07 -44.24% | 3,85 3,89 -0.9% | 5,47 5,85 -6.45% | 0,37 0,72 -48.44% | 1,44 |
Announcement Date | 28/01/20 | 02/02/21 | 08/02/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 25 661 24 734 3.75% | 27 742 26 199 5.89% | 22 638 21 091 7.33% | 24 290 24 393 -0.42% | 18 282 16 488 10.88% | 12 734 13 398 -4.96% | 13 232 13 429 -1.47% | 14 249 14 396 -1.02% | 14 879 13 923 6.87% | 13 050 | 14 847 | 17 770 | 15 680 | 13 725 |
EBITDA Million USD | Released Forecast Spread | 11 135 13 710 -18.78% | 13 583 12 434 9.25% | 10 325 10 332 -0.06% | 6 772 7 436 -8.92% | 7 857 7 513 4.58% | 4 925 4 000 23.13% | -1 244 -1 511 17.64% | 1 340 -1 298 203.24% | 4 403 | 3 759 | 4 681 | 4 537 | ||
EBIT Million USD | Released Forecast Spread | 9 948 9 738 2.16% | 12 408 11 055 12.24% | 9 142 9 092 0.55% | 5 253 6 886 -23.71% | 6 370 6 471 -1.56% | 3 319 3 634 -8.68% | -1 625 -1 827 11.07% | -330 -1 404 76.5% | 5 912 3 667 61.24% | 3 423 | 3 804 | 3 977 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 050 | 5 231 7 425 -29.55% | -3 352 2 207 -251.88% | -4 129 -3 139 -31.54% | 3 421 2 992 14.34% | 1 962 | 2 926 | 3 380 | ||||||
Net income Million USD | Released Forecast Spread | 7 864 8 418 -6.58% | 9 906 9 799 1.09% | 8 608 7 631 12.8% | 4 995 5 667 -11.86% | 5 543 4 495 23.31% | 2 327 | -2 382 -3 241 26.49% | -3 369 -2 371 -42.12% | 3 115 1 951 59.69% | 1 496 | 2 046 | 2 679 | ||
EPS USD | Released Forecast Spread | 1,37 1,60 -14.17% | 1,73 1,64 5.73% | 1,51 1,37 10.21% | 0,87 0,69 25.48% | 0,97 0,85 14.79% | 0,41 | -0,42 -0,51 16.83% | -0,60 -0,43 -41.06% | 0,55 0,34 61.01% | 0,25 | 0,36 | 0,47 | ||
Announcement Date | 03/05/22 | 28/07/22 | 01/11/22 | 31/01/23 | 02/05/23 | 01/08/23 | 31/10/23 | 30/01/24 | 01/05/24 | - | - | - | - | - |
Past sector events for Pfizer, Inc.
16/05/2024 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
16/05/2024 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
15/05/2024 15:05 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
15/05/2024 06:30 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
15/05/2024 12:40 | CRESCO LABS INC.: Q1 2024 Earnings Release |
15/05/2024 08:03 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
14/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
14/05/2024 22:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
14/05/2024 09:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
14/05/2024 06:30 | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PFE Stock
- PFE Stock
- Calendar Pfizer, Inc.